Acute Myeloid Leukemia with CEBPA Mutation

Acute Myeloid Leukemia with CEBPA Mutation — Rankings · CancerIndex

Rankings

Why this rank?

2 current ranking rows (latest year per scope). Each row lists the scope, the formula version, the value and the exact inputs that produced it.

Metric	Scope	Rank / eligible	Δ	Value	Percentile	Confidence	Formula	Generated	Inputs
Curated clinical evidence items	World · both sexes · all ages · latest · all malignant entities	#250 / 492	=	5 count	49.3	Medium confidence	ci-civic-evidence-v1	Sep 29, 2026	show formula: COUNT(civic_evidence_items) WHERE status = ACCEPTED AND cancer_id IN descendants(cancer) counter evidenceCount computedAt 2026-09-29T06:00:20.557Z inputs hash 00ec4259c26ee135c931f5a6 Trace lineage (admin)
Genes with curated or cohort evidence	World · both sexes · all ages · latest · all malignant entities	#361 / 521	=	1 count	30.8	Medium confidence	ci-genes-v1	Sep 29, 2026	show formula: COUNT(DISTINCT gene) FROM (civic accepted evidence ∪ gdc frequency ≥ 0.05 AND cases_affected ≥ 20) counter geneCount computedAt 2026-09-29T06:00:20.557Z inputs hash dc02edfbbd5b601934401df4 Trace lineage (admin)

Computed Ranks are competition ranks (ties share a rank). Percentile = share of eligible entities ranked at or below this one in the ranking direction.

"Deadliest" is ambiguous: annual deaths, age-standardized mortality rate, mortality-to-incidence ratio and 5-year survival rank cancers differently. CancerIndex publishes each as a separate metric.

Why this rank?

Research gap